MEDIFAST INC (MED) News
Filter MED News Items
MED News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
MED News Highlights
- MED's 30 day story count now stands at 13.
- Over the past 20 days, the trend for MED's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
- LFMD, GLP and DEC are the most mentioned tickers in articles about MED.
Latest MED News From Around the Web
Below are the latest news stories about MEDIFAST INC that investors may wish to consider to help them evaluate MED as an investment opportunity.
Medifast's (MED) Holistic Health Solution, Innovation Bode WellMedifast's (MED) focus on combining lifestyle coaching with innovative health solutions and targeting diverse markets bode well amid challenges in customer acquisition and high costs. |
Is Medifast, Inc. (NYSE:MED) Expensive For A Reason? A Look At Its Intrinsic ValueKey Insights Using the 2 Stage Free Cash Flow to Equity, Medifast fair value estimate is US$54.94 Medifast is estimated... |
7 Dividend Stocks I Wouldn’t Touch With a 10-Foot PoleAvoid these seven dividend stocks to sell at all costs, as their payouts may not be a sustainable as they seem. |
Potential 300% Upside: Uncovering Medifast's Investment OpportunityA look at the company's innovative wellness, robust growth and investment upside |
Medifast (MED) Collaborates With LifeMD, Discontinues DividendMedifast (MED) penetrates the medically supported weight loss market via a collaboration with LifeMD, Inc. (LFMD). The company discontinues quarterly cash dividends. |
S&P 500, Nasdaq Higher After Upbeat PPI ReadingWall Street is holding its breath ahead of this afternoon's interest rate decision from the Federal Reserve. |
Once an Ozempic Skeptic, This Diet-Company Giant Has Changed Its MindInvestment in telehealth provider LifeMD would give Medifast customers access to doctors who can prescribe the medications. |
Once Powell Is Out of the Way, I'm Getting Back to Small CapsAfter today's meeting, we should have some better opportunities for positioning. Also, let's take another look at this small health care stock. |
LifeMD Stock Pops on Medifast Agreement. It’s All About Weight-Loss Drugs.Shares of LifeMD were rising sharply Wednesday after the provider of virtual primary care services said it was teaming up with Medifast —a health and wellness company known for its lifestyle service Optavia—to present a ”transformative weight management solution.” Under the agreement, Medifast will use LifeMD virtual care technology platform to provide Optavia clients access to a weight management program that includes GLP-1 medications, drugs that mimic natural hormones that impact the body’s feelings of fullness. |
Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, a Virtual Primary Care Provider, and Adjusting its Capital Allocation PolicyBALTIMORE, December 13, 2023--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today launched the first phase of its business transformation, as part of its commitment to providing comprehensive health and wellness solutions to customers across the United States. The company will expand into the medically supported weight loss market through a collaboration with LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual |